$ARIA Recent News Ariad takes another pounding after

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
$ARIA Recent News

Ariad takes another pounding after leukemia treatment is pulled 12:14 p.m. Oct. 31, 2013 - Russ Britt
H-P has best day in four months on upbeat outlook 3:34 p.m. Oct. 9, 2013 - Sue Chang
Ariad plummets 70% after drug test patients have serious clotting issues 10:38 a.m. Oct. 9, 2013 - Russ Britt
FDA places partial hold on Ariad's Iclusig trials 7:16 a.m. Oct. 9, 2013 - MarketWatch.com
Dan Loeb makes bet on Disney 7:06 p.m. Aug. 14, 2013 - David Benoit
Onyx share surge lifts several boats in biotech harbor, including ETFs 10:33 a.m. July 1, 2013 - Russ Britt
SAC Capital Advisors likes this pharma stock 3:24 p.m. April 18, 2013 - Insider Monkey
Ariad Pharma up 6% to $20.09 10:35 a.m. Dec. 17, 2012 - Steve Gelsi
FDA OKs Iclusig to treat rare types of leukemia 1:06 p.m. Dec. 14, 2012 - MarketWatch.com
Stocks: Investors play the waiting game 8:53 a.m. Dec. 11, 2012 - The Trading Deck
12 biotech stocks hit 52-week highs 2:43 p.m. July 27, 2012 - Val Brickates Kennedy
Three rules for short selling 12:01 a.m. Feb. 2, 2012 - The Trading Deck
Stocks to watch Wednesday: C.R. Bard, Papa John’s 6:52 a.m. Dec. 21, 2011 - MarketWatch
Don't be a fan when investing 8:26 a.m. Dec. 20, 2011 - The Trading Deck
Drug stocks move higher in late trading 2:26 p.m. March 24, 2011 - Val Brickates Kennedy
Tuesday’s biggest gaining and declining stocks 5:12 p.m. Jan. 18, 2011 - Kate Gibson
Ariad soars as drug indexes move higher 12:47 p.m. Jan. 18, 2011 - Val Brickates Kennedy
Ariad rallies as drug indexes modestly rise 10:23 a.m. Jan. 18, 2011 - Val Brickates Kennedy
Aria rockets on cancer drug data 9:38 a.m. Jan. 18, 2011 - Val Brickates Kennedy
Ariad jumps on leukemia drug data 3:46 p.m. Dec. 6, 2010 - Val Brickates Kennedy


10-Q: ARIAD PHARMACEUTICALS INC 4:36 p.m. Nov. 12, 2013 - Edgar Online - (EDG = 10Q, 10K)
Ariad Pharmaceuticals Management Discusses Q3 2013 Results - Earnings Call Transcript 2:30 p.m. Nov. 12, 2013 - Seeking Alpha
Sirius XM Will Host Baseball Giant Joe Torre and 2 Other Hot Stocks to Watch 12:14 p.m. Nov. 12, 2013 - Wall St. Cheat Sheet
ARIAD Pharmaceuticals, Inc. Discusses Q3 2013 Results (Webcast) 8:25 a.m. Nov. 12, 2013 - Seeking Alpha
Health-Care Stocks: Where to Find Value 6:07 a.m. Nov. 12, 2013 - Barrons.com
JPMorgan Considers Ban on Trader Chat Rooms and 2 Other Hot Stocks to Watch 12:17 p.m. Nov. 11, 2013 - Wall St. Cheat Sheet
Benzinga's Top #PreMarket Gainers 7:13 a.m. Nov. 11, 2013 - benzinga.com
Shire, Novartis Deals: Pharmaceutical Shakeups Continue 6:55 a.m. Nov. 11, 2013 - 247WallSt.com
EMA's PRAC Updates On The Risks Of Serious Vascular Occlusive Events Associated With Cancer Medicine Iclusig 8:37 a.m. Nov. 8, 2013 - benzinga.com
ARIAD Shares Tumble on Iclusig Woes - Analyst Blog 5:20 p.m. Nov. 7, 2013 - Zacks.com
ARIAD to Cut 40% of US Staff Positions 3:18 p.m. Nov. 7, 2013 - benzinga.com
Ariad Pharmaceuticals (ARIA) Marked As A Dead Cat Bounce Stock 9:45 a.m. Nov. 6, 2013 - TheStreet.com
6 Biotechnology Stocks to Buy Now 5:15 a.m. Nov. 6, 2013 - InvestorPlace.com
Canada Said to Have Blocked BlackBerry Takeover and 2 More Heavily Traded Stocks to Follow 4:59 p.m. Nov. 5, 2013 - Wall St. Cheat Sheet
The Drive Behind Ariad Pharmaceuticals' (ARIA) Partial Recovery 1:51 p.m. Nov. 4, 2013 - TheStreet.com
Ford Sees October Gains, Netflix Rides an Upgrade, and 3 More Hot Stocks 1:52 p.m. Nov. 1, 2013 - Wall St. Cheat Sheet
2013 Biotech Watchlist Update: Companies Climb And Crumble On Catalysts 11:48 a.m. Nov. 1, 2013 - Seeking Alpha
Are You Betting Too Much On Theravance? 11:28 a.m. Nov. 1, 2013 - Seeking Alpha
Analysts: Facebook Could Add $3B in Revenue and 3 More Research Notes to Browse 10:22 a.m. Nov. 1, 2013 - Wall St. Cheat Sheet
Biotech Stock Mailbag: Chelsea's FDA Panel, Ariad's Future, Bio-Bubble Update 6:00 a.m. Nov. 1, 2013 - TheStreet.com


ARIA, DNDN, HSOL and OREX added to NASDAQ Active Stock Watch List at EPR 9:29 a.m. Nov. 12, 2013 - ACCESSWIRE
Shareholder Rights Law Firm Johnson & Weaver, LLP Files Derivative Lawsuit on behalf of ARIAD Pharmaceuticals, Inc. 9:29 a.m. Nov. 12, 2013 - BusinessWire
ARIAD Reports Third Quarter 2013 Financial Results and Announces Significant Expense Reduction 7:35 a.m. Nov. 12, 2013 - BusinessWire
Glancy Binkow & Goldberg Announces a December 9, 2013 Lead Plaintiff Deadline in the Class Action Lawsuit Against ARIAD Pharmaceuticals, Inc. - ARIA 9:10 a.m. Nov. 11, 2013 - GlobeNewswire
News and Updates on ARIA, AFYG and ASAB 1:27 a.m. Nov. 8, 2013 - ACCESSWIRE
ARIAD Announces Reduction in U.S. Workforce as Part of Broad Program to Reduce Operating Expenses 4:05 p.m. Nov. 7, 2013 - BusinessWire
Financial Results and Upcoming Conference Calls - Research Report on Ariad, Idenix, Osiris, InterMune, and Array BioPharma 8:00 a.m. Nov. 6, 2013 - PR Newswire
Harwood Feffer LLP Announces Investigation of Ariad Pharmaceuticals, Inc. 8:10 p.m. Nov. 5, 2013 - PR Newswire
Top Trial Firm Cohen, Placitella & Roth, PC Investigating Ariad Pharmaceuticals, Inc., for Suspending Sales of its Leukemia Drug Iclusig 12:50 p.m. Nov. 5, 2013 - PR Newswire
Stock Price Movement Update, Recognitions, and Financial Results - Research Report on Ariad Pharmaceuticals, Quintiles, Molina Healthcare, Exelixis, and Masimo 8:00 a.m. Nov. 4, 2013 - PR Newswire
Today's Equity Reports on BZNE, ARIA, AXPW and SPDL 2:25 a.m. Nov. 4, 2013 - ACCESSWIRE
Law Offices of Howard G. Smith Announces Lead Plaintiff Deadline In The Class Action Lawsuit Against ARIAD Pharmaceuticals, Inc. 9:32 p.m. Nov. 1, 2013 - BusinessWire
Morning Research: Ariad Pharma Inc., MannKind Corp., Novavax Inc., and Galena Biopharma Inc. 1:30 p.m. Nov. 1, 2013 - PR Newswire
ARIAD Adopts Shareholder Rights Plan to Preserve Valuable Net Operating Loss Carryforwards and Other Tax Benefits 8:35 a.m. Nov. 1, 2013 - BusinessWire
ARIAD Announces Change to the Date of Its Third Quarter 2013 Financial Results Conference Call and Webcast to November 12, 2013 4:30 p.m. Oct. 31, 2013 - BusinessWire
ARIAD Announces Temporary Suspension of Iclusig Marketing in the United States 7:30 a.m. Oct. 31, 2013 - BusinessWire
ARIAD PHARMACEUTICALS, INC. SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against ARIAD Pharmaceuticals, Inc. and Its Board and a Lead Plaintiff Deadline of December 9, 2013 -- ARIA 3:36 p.m. Oct. 30, 2013 - GlobeNewswire
Sector Leaders Briefing & Capital Raise News: Muscle Warfare, Baidu, Herblife, Gilead Sciences and ARIAD 9:08 a.m. Oct. 30, 2013 - PR Newswire
Ariad Pharmaceuticals Shareholder Alert: Former SEC Attorney Willie Briscoe and Powers Taylor Investigate Possible Breaches of Fiduciary Duty by Officers and Directors 3:30 p.m. Oct. 29, 2013 - BusinessWire
Insider Trading Reports for Intel, Charles Schwab, Fusion-IO, J.C. Penney, Bristol-Myers Squibb, and Ariad Pharmaceuticals 8:55 a.m. Oct. 29, 2013 - PR Newswire

Scroll down for more posts ▼

Top 10 Most Recent News Articles

2026 Rawlings Gold Glove Award Winners Announced

Updated Category News Views 65

Fielding Excellence on Display: The 2026 Rawlings Gold Glove Awards The Rawlings Gold Glove Awards have once again shone the spotlight on baseball's defensive maestros. Announced by Rawlings Sporting Goods Company, Inc., on November 1, 2026, this year's winners include 11 seasoned veterans and nine greenhorns who claimed their first-ever Gold Gloves. Unveiled during a...

Continue Reading
Knob-and-Tube Wiring: A Hidden Hazard Unveiled

Updated Category News Views 185

Unlocking the Mysteries of Knob-and-Tube Wiring Ever wondered if the wiring in your charming hundred-year-old home might be a ticking time bomb? Welcome to the world of knob-and-tube wiring. This blast from the past might just be hiding in those walls and could spell trouble. The History and Hazards of Knob-and-Tube This wiring system dates back to the 1880s, sticking...

Continue Reading
Double Down for Veterans Raises $20 Million Goal

Updated Category News Views 219

Helping Veterans: A Call That Never Fades If there's one thing that never changes, it's the enduring need to support those who have served. Semper Fi & America's Fund has been at the forefront of this mission for over a decade, and their annual Double Down for Veterans Match Campaign is nothing short of a testament to unwavering commitment. Kicking off for the 15th time,...

Continue Reading
Mastering Progressive Overload: Break Workout Plateaus

Updated Category News Views 149

Getting off the Fitness Merry-Go-Round You've been hitting the gym, feeling great, and suddenly—bam! You've hit a wall so hard you might as well be a bug on a windshield. That's where our buddy Joshua Bankes comes in, explaining the magic of progressive overload for fitness buffs. Understanding Plateau Phenomena Remember, results aren't linear. As you start a new...

Continue Reading
Decoding Real Estate Value: A Market Insider's Take

Updated Category News Views 328

Riding the Waves of Real Estate Pricing Homeowners dipping their toes into the real estate market know that setting the right price ain't a walk in the park. Luckily, Matt Nuzie, Shelton's real estate pro, has peeled back the layers on comparative market analyses (CMA) in a HelloNation piece. This isn't just about tossing a number out there—it's about understanding the...

Continue Reading
New Era Celebrates Valkyries' Groundbreaking WNBA Win

Updated Category News Views 157

A Surprising Win for a Rising Team In the world of sports, sometimes the odds are defied, and stories of triumph unfold that capture the imagination. The Golden State Valkyries did exactly that by snagging their first WNBA Championship title just a year after entering the league. It's a narrative right out of a Hollywood script—only this time, it's inked in real...

Continue Reading
Global Mayors Dialogue 2026: Ningbo Leads in Urban Ideas

Updated Category News Views 68

New Waves in City Collaboration Get this: from November 2 to 5, Ningbo, a key city nestled in east China's Zhejiang Province, is rolling out the red carpet for the 2026 Global Mayors Dialogue. Nearly 200 influential figures zooming into this seaside city isn't just for some aimless chit-chat. At the core, the theme is "Openness and Connectivity for Shared Opportunities."...

Continue Reading
China's Innovation Surge: Game Changer for Global Markets

Updated Category News Views 74

The Bold Shift in China's Economic Landscape Well, here's the scoop: China isn't just the world's assembly line anymore; it's gearing up to be a top-tier innovation hub. On the surface, might seem like another geopolitical spiel, but dig a little and you'll find it's a serious shake-up for global markets. We're talking about more than just products rolling out of...

Continue Reading
Chiropractic Insights: Differentiating Piriformis vs. Disc Pain

Updated Category News Views 196

Understanding Pain: Two Paths, One Problem Buttock and leg pain is a real drag, isn't it? We often brush it off as sciatica, but here's a twist: it might not be the usual corporate villain—a herniated disc. Instead, we could be dealing with an underdog called piriformis syndrome. According to Dr. Mitch Quill, D.C., of HelloNation fame, understanding these nuances isn't...

Continue Reading
iQIYI's AI Studio: Future of Filmmaking or Flash in Pan?

Updated Category News Views 8

Introducing the AI Revolution in Film Here we are, folks, standing at the intersection of film and artificial intelligence. China's entertainment behemoth, iQIYI, has just launched what they're touting as the country's first AI Film Studio over in Shanghai. Kicking things off, they've got "Cop in Trouble" queued up, a film that’s promising to leverage the unbridled...

Continue Reading

Top 5 Most Recently Viewed Articles

Benitec Biopharma Reports Operational Gains Amid Financial Update

Updated Category News Views 82

Benitec Biopharma's Recent Financial and Operational Developments It's an exciting period for Benitec Biopharma Inc. as they unveil substantial progress in their clinical endeavors, particularly regarding the BB-301 gene therapy. This innovative treatment aims at addressing the challenges posed by Oculopharyngeal Muscular Dystrophy (OPMD), a rare genetic condition. The...

Continue Reading
Idorsia's Progress on Negotiations for Aprocitentan Rights

Updated Category News Views 156

Idorsia's Recent Developments on Aprocitentan Negotiations Idorsia Ltd today announced important updates regarding its ongoing negotiations for the global rights to its drug, aprocitentan. This pivotal medication has the potential to significantly impact patient care and is currently the subject of exclusive negotiations with an unnamed party. Originally, the company had...

Continue Reading
Neuronetics Achieves Growth and Expands Treatment Options in 2024

Updated Category News Views 225

Growth Highlights for 2024 Neuronetics, Inc. (NASDAQ: STIM) is paving the way in mental health care, showcasing substantial financial results in both the fourth quarter and the full year of 2024. This vertically integrated medical technology company has made remarkable strides in making neurohealth therapies accessible to patients in need. Fourth Quarter 2024 Performance...

Continue Reading
Nano Dimension's Q2 2025 Financial Insights and Future Plans

Updated Category News Views 319

Nano Dimension's Financial Performance Overview Nano Dimension Ltd. (NASDAQ: NNDM), known for its digital manufacturing solutions, has recently shared its impressive financial results for the second quarter, closing on June 30, 2025. Despite the backdrop of industry challenges, the company's revenue reached $25.8 million, reflecting a remarkable increase of 72.4% compared...

Continue Reading
Bridging Art and Science Through Creative Collaborations

Updated Category News Views 288

Collaboration Between CALQ and Université du Québec à Rimouski The CALQ (Conseil des arts et des lettres du Québec) has partnered with Université du Québec à Rimouski (UQAR) to create an exceptional bridge between the worlds of art and science. This partnership aims to connect artists from disciplines such as film, public art, and classical music with scientists...

Continue Reading